Novo Nordisk sues Hims after $49 weight-loss pill drama
Novo Nordisk sued Hims and Hers Health today over patent infringement after the US telehealth firm launched, then cancelled, a $49 copy of Novo's weight-loss pill Wegovy following backlash from the US Food and Drug Administration.
Business
• 3 hrs
